Symbol
| CFL1
| contributors: mct/shn/pgu - updated : 20-11-2018
|
HGNC name
| cofilin 1 (non-muscle)
|
HGNC id
| 1874
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
cofilin aggregation may contribute to neurodegeneration and brain aging by blocking intracellular trafficking and inducing synaptic loss  | tumoral
|  
|  
| --over
|  
|
significant association between overexpression of nuclear CFL1 with bladder cancer progression  | tumoral
|  
|  
| --over
|  
|
simultaneous overexpression of AURKA and CFL1 correlated with lymph node metastasis in thyroid cancer tissue  | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| not only the higher levels of CFL1, but also its nuclear localization can be proposed as marker of worse outcome of patients with melanoma  | |
positive expression of UGP2 and CFL1 can serve a valuable prognostic factor in pancreatic cancer  | |
cytoskeletal cofilin is potential tumor marker of invasive bladder cancer | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | urinary | |  |
targetable platforms for the treatment of invasive bladder cancer | cancer | endocrine | thyroid |  |
possibility of targeting AURKA and CFL1 for more effective treatment of thyroid cancer | cancer | hemopathy | |  |
targeting CFL1 might therefore provide another novel approach for treatment of Ewing sarcoma |
| | |
| Loss of n-cofilin impairs radial migration, resulting in the lack of intermediate cortical layers  |